Briumvi 25 mg/ml
Briumvi 25 mg/ml is a medicine authorised by Swissmedic under authorisation number 69599. The authorisation holder is Neuraxpharm Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 06 February 2025 and the authorisation is limited until 05 February 2030. ATC code L04AG14 places the medicine in the group Immunosuppressants.
| Authorisation number | 69599 |
|---|---|
| Name | Briumvi 25 mg/ml |
| Full name | Briumvi 25 mg/ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Neuraxpharm Switzerland AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L04AG14 |
| First authorisation | 06 February 2025 |
| Authorisation validity | 05 February 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Briumvi 25 mg/ml, Konzentrat zur Herstellung einer Infusionslösung | A | 06 February 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L04AG14 | 07.15.0. | A |
| 2 | 3 | Durchstechflasche(n) | L04AG14 | 07.15.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Briumvi 25 mg/ml authorised in Switzerland?
Yes. Briumvi 25 mg/ml is authorised by Swissmedic under authorisation number 69599, data as of 01 September 2026. The authorisation is limited until 05 February 2030.
Which dispensing category does Briumvi 25 mg/ml have?
Briumvi 25 mg/ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Briumvi 25 mg/ml?
The authorisation holder is Neuraxpharm Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.